Who is sponsoring NCT05117073?

NCT05117073 is sponsored by Sohag University.

What drugs are being tested in NCT05117073?

Interventions in NCT05117073: ASCITIC FLUID CULTURE.

What condition does NCT05117073 study?

NCT05117073 studies Spontanous Fungal Peritonitis.

Is NCT05117073 still recruiting?

NCT05117073 is currently completed. Last updated 12 May 2023.

Last reviewed 2023-05-12 · How we verify

NCT05117073

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Risk Factors of Spontaneous Fungal Peritonitis in Cirrhotic Patients

Completed Last updated 12 May 2023

What this trial tests

trial testing ASCITIC FLUID CULTURE in Spontanous Fungal Peritonitis in 100 participants. Completed in 29 April 2023.

Timeline

1 September 2021

Primary endpoint
30 March 2023

29 April 2023

Quick facts

Lead sponsor	Sohag University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 September 2021
Primary completion	30 March 2023
Estimated completion	29 April 2023
Sites	1 location across Egypt

Drugs / interventions tested

ASCITIC FLUID CULTURE

Conditions studied

Spontanous Fungal Peritonitis — all drugs for Spontanous Fungal Peritonitis →

Sponsor

Sohag University

Who can join

Eligibility, any sex, with Spontanous Fungal Peritonitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Spontaneous bacterial peritonitis (SBP) is an infection of the peritoneal cavity with no surgically treatable intra-abdominal source of infection. Spontaneous peritonitis is a potentially fatal complication in patients with advanced liver cirrhosis. It is estimated that 10-20 % of patients with cirrhotic ascites may develop spontaneous peritonitis, which is usually caused by a bacterial infection. In contrast, spontaneous fungal peritonitis (SFP) is less well-recognized. SFP may be associated with higher mortality rates than SBP but therapeutic approaches are largely undefined. To this end, the epidemiology and outcomes of patients with SFP have only been documented sporadically aimed to evaluate the risk factors for the development of spontaneous fungal peritonitis (SFP), and the prognosis of SFP compared with SBP

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05117073 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 12 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05117073.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing